发明申请
US20120078028A1 ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS
有权
抗体药物联合（ADC），它与191P4D12蛋白质
- 专利标题： ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 191P4D12 PROTEINS
- 专利标题（中）： 抗体药物联合（ADC），它与191P4D12蛋白质
-
申请号： US13249111申请日： 2011-09-29
-
公开(公告)号： US20120078028A1公开(公告)日： 2012-03-29
- 发明人: Daulet SATPAYEV , Robert Kendall Morrison , Karen Jane Meyrick Morrison , Jean Gudas , Aya Jakobovits , Michael Torgov , Zili An
- 申请人： Daulet SATPAYEV , Robert Kendall Morrison , Karen Jane Meyrick Morrison , Jean Gudas , Aya Jakobovits , Michael Torgov , Zili An
- 主分类号： A61N5/00
- IPC分类号： A61N5/00 ; A61K39/395 ; A61P35/00 ; C07K16/28
摘要：
Antibody drug conjugates (ADC's) that bind to 191P4D12 protein and variants thereof are described herein. 191P4D12 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, the ADC's of the invention provide a therapeutic composition for the treatment of cancer.
公开/授权文献
信息查询
